I agree completely. One user on the Yahoo Finances Message Board for GERN had a very good breakdown of what made the article subjectively bad - sdrawcabeman.
The article itself wasn’t grounded in facts and a lot of the data and basic medical terminology were misinterpreted or misunderstood - including the understanding of what the medicine does and who the patients it would treat are, and so on.
In my opinion, the author looked to be after benefiting from a drop in GERN share price. And the disclaimer at the end was very contradictory. “I am not receiving compensation for this article” “I am a GERN short”.
Writing a hit piece on a forum that’s relatively popular to make money looks very bad on the community as a whole.
I agree completely. One user on the Yahoo Finances Message Board for GERN had a very good breakdown of what made the article subjectively bad - sdrawcabeman.
The article itself wasn’t grounded in facts and a lot of the data and basic medical terminology were misinterpreted or misunderstood - including the understanding of what the medicine does and who the patients it would treat are, and so on.
In my opinion, the author looked to be after benefiting from a drop in GERN share price. And the disclaimer at the end was very contradictory. “I am not receiving compensation for this article” “I am a GERN short”.
Writing a hit piece on a forum that’s relatively popular to make money looks very bad on the community as a whole.